AstraZeneca has announced an ambitious plan to invest £50 billion in the United States by the end of the decade. This significant move is expected to bolster the company’s manufacturing
AstraZeneca has announced an ambitious plan to invest £50 billion in the United States by the end of the decade. This significant move is expected to bolster the company’s manufacturing






